SNX18P10

Across TCGA pan-cancer cohorts, SNX18P10 RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated SNX18P10 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher SNX18P10 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SNX18P10 expression acts as an unfavorable survival marker.

MESO, KIRP, and SKCM are the cancer types where SNX18P10 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.077	0.580	<.001	99	view →
KIRP	DFS	Tertile	All	0.205	0.871	<.001	93	view →
SKCM	DFS	Tertile	II,III,IV	0.475	0.734	.004	21	view →
STAD	DFS	Tertile	III,IV	0.450	0.620	.045	9	view →
GBM	OS	Tertile	All	0.212	0.442	.010	9	view →
KIRC	DFS	Tertile	All	0.314	0.642	.024	6	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

SNX18P10–MESO (OS)

Open the MESO breakdown →